careviso, a Falls Church, VA-based healthcare technology company, raised over $17M in Series B funding.
The round was led by Ballast Point Ventures with participation from Mercury and Lytical Ventures.
The company intends to use the funds to expand its existing technology platform into the diagnostic space.
Led by CEO Andrew Mignatti, careviso is a healthcare technology company whose technology platform increases patient access to care by delivering cost estimates, administrative requirements, and approvals in real time. The platform, seeQer, is directly aligned with the No Surprises Act, which protects individuals covered under a variety of health plans from receiving surprise medical bills months after a service or procedure. The product aims to solve the requirements surrounding the Good Faith Estimate and the Advanced Explanation of Benefits, for diagnostic services, at the point of care or ahead of time.
The company currently serves a substantial customer base in the women’s healthcare space, with over 50% of OBGYN clinics in the U.S. working with careviso. While OBGYN and oncology remain careviso’s core therapeutic areas, the company is prioritizing expansion into other therapeutic areas with an increased focus on patient access, including radiology and endoscopy.
The company also has an operations center in Orlando, Florida.
FinSMEs
29/09/2022